Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris

Cardiology. 2006;105(1):17-21. doi: 10.1159/000088266. Epub 2005 Sep 15.

Abstract

The aim of this study was to examine the effect of pharmacological modulation of the ATP-sensitive potassium channels in the development of warm-up angina pectoris. Thirty-one patients with stable angina pectoris, a positive exercise test and angiographically documented coronary artery disease underwent three exercise tests 90 min after receiving either glibenclamide 10.5 mg (an ATP-sensitive potassium channel blocker), pinacidil 25 mg (an ATP-sensitive potassium channel opener) or placebo in a blinded fashion. There was a 30-min recovery period between the first and the second test and 60 min between the second and the third test. The rate-pressure product at 1-mm ST-segment depression (ischemic threshold) and the maximum ST-segment depression (STD) adjusted to the highest rate-pressure product common to the three tests were analyzed. In the placebo group, there was a significant increase in the ischemic threshold during the second and third test and a significant decrease in the maximum adjusted STD during the second test which was lost during the third test. This apparent adaptation to exercise-induced ischemia was not seen in the glibenclamide-treated patients. In the pinacidil-treated patients, there was a paradoxical decrease in ischemic threshold during the second test with no change in maximum adjusted STD which tended to be lower than in the placebo-treated patients on each exercise test. This study confirms that the warm-up phenomenon can be induced during repeated exercise testing. The blockade of this phenomenon by glibenclamide suggests that the ATP-sensitive potassium channels may be involved in this potential protective mechanism. At the same time, the paradoxical response in the pinacidil-treated patients flags a warning that drugs acting on the sarcolemmal ATP-sensitive potassium channels may have a direct effect on the ST-segment that may interfere with the interpretation of the electrocardiogram.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Aged
  • Angina Pectoris / drug therapy*
  • Angina Pectoris / metabolism
  • Angina Pectoris / physiopathology
  • Anti-Arrhythmia Agents / pharmacology
  • Blood Pressure / drug effects
  • Double-Blind Method
  • Electrocardiography
  • Exercise Test
  • Female
  • Glyburide / pharmacology*
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Pinacidil / pharmacology*
  • Potassium Channel Blockers / pharmacology*
  • Treatment Outcome
  • Vasodilator Agents / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Potassium Channel Blockers
  • Vasodilator Agents
  • Pinacidil
  • Adenosine Triphosphate
  • Glyburide